- call +1-201-465-4211
- email sales@mrinsights.biz
Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.
Scope of the Report:
This report focuses on the Peripheral Intervention Drug-Eluting Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Peripheral Intervention Drug-Eluting Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. Bard, Inc.
St. Jude Medical, Inc.
The Lubrizol Corporation
Terumo Corporation
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Plain Old Balloon Angioplasty (POBA)
Percutaneous Transluminal Angioplasty (PTA)
Market Segment by Applications, can be divided into
Drug-Eluting Balloons
Drug-Eluting Stents
There are 15 Chapters to deeply display the global Peripheral Intervention Drug-Eluting Devices market.
Chapter 1, to describe Peripheral Intervention Drug-Eluting Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Peripheral Intervention Drug-Eluting Devices, with sales, revenue, and price of Peripheral Intervention Drug-Eluting Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Peripheral Intervention Drug-Eluting Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Peripheral Intervention Drug-Eluting Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Peripheral Intervention Drug-Eluting Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Peripheral Intervention Drug-Eluting Devices Introduction
1.2 Market Analysis by Type
1.2.1 Plain Old Balloon Angioplasty (POBA)
1.2.2 Percutaneous Transluminal Angioplasty (PTA)
1.3 Market Analysis by Applications
1.3.1 Drug-Eluting Balloons
1.3.2 Drug-Eluting Stents
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Medtronic plc
2.1.1 Business Overview
2.1.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Boston Scientific Corporation
2.2.1 Business Overview
2.2.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Abbott Laboratories
2.3.1 Business Overview
2.3.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Cardinal Health
2.4.1 Business Overview
2.4.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 B. Braun Melsungen AG
2.5.1 Business Overview
2.5.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Biosensors International Group Ltd.
2.6.1 Business Overview
2.6.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 C.R. Bard, Inc.
2.7.1 Business Overview
2.7.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 St. Jude Medical, Inc.
2.8.1 Business Overview
2.8.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 St. Jude Medical, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 The Lubrizol Corporation
2.9.1 Business Overview
2.9.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Terumo Corporation
2.10.1 Business Overview
2.10.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Peripheral Intervention Drug-Eluting Devices Manufacturer Market Share in 2017
3.3.2 Top 6 Peripheral Intervention Drug-Eluting Devices Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Peripheral Intervention Drug-Eluting Devices Market Analysis by Regions
4.1 Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Regions (2013-2018)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Regions (2013-2018)
4.2 North America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
4.3 Europe Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
4.5 South America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
5 North America Peripheral Intervention Drug-Eluting Devices by Countries
5.1 North America Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
5.1.1 North America Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018)
5.1.2 North America Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018)
5.2 United States Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
5.3 Canada Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
5.4 Mexico Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
6 Europe Peripheral Intervention Drug-Eluting Devices by Countries
6.1 Europe Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
6.1.1 Europe Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018)
6.2 Germany Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
6.3 UK Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
6.4 France Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
6.5 Russia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
6.6 Italy Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
7 Asia-Pacific Peripheral Intervention Drug-Eluting Devices by Countries
7.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018)
7.2 China Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
7.3 Japan Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
7.4 Korea Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
7.5 India Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
8 South America Peripheral Intervention Drug-Eluting Devices by Countries
8.1 South America Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
8.1.1 South America Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018)
8.1.2 South America Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
8.3 Argentina Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
8.4 Colombia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
9 Middle East and Africa Peripheral Intervention Drug-Eluting Devices by Countries
9.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
9.3 UAE Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
9.4 Egypt Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
9.5 Nigeria Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
9.6 South Africa Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
10 Global Peripheral Intervention Drug-Eluting Devices Market Segment by Type
10.1 Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Type (2013-2018)
10.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Type (2013-2018)
10.2 Plain Old Balloon Angioplasty (POBA) Sales Growth and Price
10.2.1 Global Plain Old Balloon Angioplasty (POBA) Sales Growth (2013-2018)
10.2.2 Global Plain Old Balloon Angioplasty (POBA) Price (2013-2018)
10.3 Percutaneous Transluminal Angioplasty (PTA) Sales Growth and Price
10.3.1 Global Percutaneous Transluminal Angioplasty (PTA) Sales Growth (2013-2018)
10.3.2 Global Percutaneous Transluminal Angioplasty (PTA) Price (2013-2018)
11 Global Peripheral Intervention Drug-Eluting Devices Market Segment by Application
11.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2013-2018)
11.2 Drug-Eluting Balloons Sales Growth (2013-2018)
11.3 Drug-Eluting Stents Sales Growth (2013-2018)
12 Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
12.1 Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Growth Rate (2018-2023)
12.2 Peripheral Intervention Drug-Eluting Devices Market Forecast by Regions (2018-2023)
12.2.1 North America Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
12.2.2 Europe Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
12.2.3 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
12.2.4 South America Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
12.2.5 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
12.3 Peripheral Intervention Drug-Eluting Devices Market Forecast by Type (2018-2023)
12.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2018-2023)
12.3.2 Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Type (2018-2023)
12.4 Peripheral Intervention Drug-Eluting Devices Market Forecast by Application (2018-2023)
12.4.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2018-2023)
12.4.2 Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Peripheral Intervention Drug-Eluting Devices Picture
Table Product Specifications of Peripheral Intervention Drug-Eluting Devices
Figure Global Sales Market Share of
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
